Background: Platelet-rich plasma (PRP) is an autologous product prepared from peripheral blood that contains a platelet concentration above the baseline and a complex composition of the blood components, excluding red blood cells and a rich source of biologically active proteins and growth factors that play an important role in reducing inflammation, angiogenesis, cell migration, cell differentiation and metabolism. The treatment of Musculoskeletal soft tissue injuries and tendinopathies using PRP has received increasing attention recently and has become an interesting field. These are common in adults who take part in sports activities and represent a significant burden to society in terms of personal disability. Objective: To evaluate the functional outcome of Platelet-Rich Plasma in sports-associated tendon injury and tendinopathy Material and Methods: This study was a prospective study carried out in 30 patients. The patients were assessed pre-procedure and post-procedure in the form of range of movements, pain, tenderness, joint stiffness and early mobilization. The quantity of PRP given was 2 ml and the same was repeated based upon the response in follow-up period. The functional outcome of PRP treatment was evaluated with visual analogue score Result: Maximum study participants were in 26-35 years of age group and were males. The rotator cuff tendon was most commonly affected (40%) followed by the hamstring tendon. 63.3% of patients improved within 4 weeks of PRP injection, 33.3% improved within 8 weeks and only one patient took more than 8 weeks in improvement. Only two patients were presented with a short-term increase in pain and one with skin discolouration. 73.3% of patients had excellent results following PRP, 20% had good results and 6.7% had fair results as per the VAS scoring Conclusion: The functional outcome of Platelet-Rich Plasma in sports-associated tendon injury and tendinopathy was excellent with minimum complications.